225 related articles for article (PubMed ID: 23166734)
1. CD95 is part of a let-7/p53/miR-34 regulatory network.
Hau A; Ceppi P; Peter ME
PLoS One; 2012; 7(11):e49636. PubMed ID: 23166734
[TBL] [Abstract][Full Text] [Related]
2. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
Müller M; Wilder S; Bannasch D; Israeli D; Lehlbach K; Li-Weber M; Friedman SL; Galle PR; Stremmel W; Oren M; Krammer PH
J Exp Med; 1998 Dec; 188(11):2033-45. PubMed ID: 9841917
[TBL] [Abstract][Full Text] [Related]
3. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
4. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
[TBL] [Abstract][Full Text] [Related]
5. Micro(mi) RNA-34a targets protein phosphatase (PP)1γ to regulate DNA damage tolerance.
Takeda Y; Venkitaraman AR
Cell Cycle; 2015; 14(24):3830-41. PubMed ID: 26111201
[TBL] [Abstract][Full Text] [Related]
6. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
7. CD95 ligand induces senescence in mismatch repair-deficient human colon cancer via chronic caspase-mediated induction of DNA damage.
Raats DA; Frenkel N; van Schelven SJ; Rinkes IH; Laoukili J; Kranenburg O
Cell Death Dis; 2017 Mar; 8(3):e2669. PubMed ID: 28300842
[TBL] [Abstract][Full Text] [Related]
8. Involvement of miR-605 and miR-34a in the DNA damage response promotes apoptosis induction.
Zhou CH; Zhang XP; Liu F; Wang W
Biophys J; 2014 Apr; 106(8):1792-800. PubMed ID: 24739178
[TBL] [Abstract][Full Text] [Related]
9. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
Ruiz-Ruiz MC; López-Rivas A
Cell Death Differ; 1999 Mar; 6(3):271-80. PubMed ID: 10200578
[TBL] [Abstract][Full Text] [Related]
10. miR-34 and p53: New Insights into a Complex Functional Relationship.
Navarro F; Lieberman J
PLoS One; 2015; 10(7):e0132767. PubMed ID: 26177460
[TBL] [Abstract][Full Text] [Related]
11. Micro RNA 34a and Let-7a Expression in Human Breast Cancers is Associated with Apoptotic Expression Genes.
Mansoori B; Mohammadi A; Shirjang S; Baghbani E; Baradaran B
Asian Pac J Cancer Prev; 2016; 17(4):1887-90. PubMed ID: 27221871
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
14. c-Jun N-terminal kinase 1/c-Jun activation of the p53/microRNA 34a/sirtuin 1 pathway contributes to apoptosis induced by deoxycholic acid in rat liver.
Ferreira DM; Afonso MB; Rodrigues PM; Simão AL; Pereira DM; Borralho PM; Rodrigues CM; Castro RE
Mol Cell Biol; 2014 Mar; 34(6):1100-20. PubMed ID: 24421392
[TBL] [Abstract][Full Text] [Related]
15. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
Chen X; Yan J; Chen T
Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 exerts oncogenic effects through microRNAs and their target gene networks.
Li XL; Jones MF; Subramanian M; Lal A
FEBS Lett; 2014 Aug; 588(16):2610-5. PubMed ID: 24726728
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
Tarasov V; Jung P; Verdoodt B; Lodygin D; Epanchintsev A; Menssen A; Meister G; Hermeking H
Cell Cycle; 2007 Jul; 6(13):1586-93. PubMed ID: 17554199
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]